Illana Gozes

Professor Emerita Tel Aviv University (TAU), formerly Lily and Avraham Gildor Chair and Director of the Adams Super Center for Brain Studies. Currently, Director, Elton Laboratory for Molecular Neuroendocrinology. B.Sc. TAU, Ph.D., Weizmann Institute of Science, postdoc. MIT and Salk Institute. Associate Professor, Weizmann Institute, Fogarty-Scholar-in-Residence, NIH, Humboldt Awardee, Germany. Mentored >65 students. Published ~350 papers (h-index 79). Inventor of multiple patents including (NAP, Davuentide), a clinical drug candidate targeted at the rare disease indication, the ADNP syndrome. Discovered ADNP, essential for brain formation implicated in autism, schizophrenia, Alzheimer’s disease and cancer. NAP is the active site of ADNP. Multiple prizes including Teva Founders Prize, Landau Prizes and best applied scientist, TAU. Ex-President, Israel Society for Neuroscience (Honorary Member), Ex-Member, Council of Higher Education. Secretary, European Society for Neurochemistry. Editor-in-Chief, Journal of Molecular Neuroscience. Chief Scientific Officer, ATED Therapeutics.